Literature DB >> 3327704

The concept of the "perisinusoidal functional unit" of the liver--importance to pathological processes.

H David1, P Reinke.   

Abstract

Non-hepatocytes account for 30 per cent of cells in the liver, with sinusoid-coating endothelial and Kupffer cells being the most common types. In addition, there are some scattered pit cells in the wall. Ito cells (perisinusoidal cells, lipocytes) are located in the Disse space. In this paper a review is given of structural and functional changes of cells in response to pathological conditions with reference to the importance of such changes due to diseases of the liver and the organism in large. Cooperation and interaction among non-hepatocytes, the vascular pole of hepatocytes, and Disse space as the site of reaction are summarised under the concept of the "Perisinusoidal Functional Unit", and the concept is explained in greater detail by examples (lipoprotein catabolism, processes of phagocytosis, vitamin A storage, virus infections, accumulation of pathological substances, fibrosis, and capillarization).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3327704     DOI: 10.1016/s0232-1513(87)80031-2

Source DB:  PubMed          Journal:  Exp Pathol        ISSN: 0232-1513


  3 in total

Review 1.  Recruitment of dendritic cells to pathological niches in inflamed liver.

Authors:  Hiroyuki Yoneyama; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

2.  Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.

Authors:  D A Piccoli; C L Witzleben; C J Guico; A Morrison; D H Rubin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease.

Authors:  H Yoneyama; K Matsuno; Y Zhang; M Murai; M Itakura; S Ishikawa; G Hasegawa; M Naito; H Asakura; K Matsushima
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.